Join 150+ attendees to explore the latest trends & strategies within Discovery Research. This fully online event will be a mixture of on-demand and live sessions so you can join the best in class scientific discussions from the comfort of your home office. This year’s conference will highlight the challenges discovery pipelines have faced due to COVID-19 and put a spotlight on the adoption of technology to combat these.
➢ AI In Drug Discovery
- Application of Artificial Intelligence in COVID-19 Drug Repurposing
- AI Driven Drug Discovery Models
➢ Lead Generation Strategies
- Hit Triage and Validation Strategies
- Chromatography-Free High-Throughput Mass Spectrometry
- The Next Generation of Biological Therapeutics – A Systematic Review
- Developing Cyclic Peptides into Therapies
➢ Fragment - Based Drug Discovery
- 3D Scaffolds for Fragment-Based Drug Discovery
- Implications of Structural Fluctuations for Fragment-Based Drug Design
➢ Preclinical Strategies, Models And Tools In Oncology
- Oncology Treatment in the Era of COVID-19
- Preclinical Collaboration to Improve Oncology Drug Development
➢ COVID-19 Spotlight: RNA As A Drug Target
- Current Approaches for the Analysis of SARS-CoV-2 RNA Polymerase as a Potential Drug Target
- Small Molecule-RNA Targeting
➢ Novel Drug Target Discovery & Validation
- State-of-the-Art Chemoproteomic Technologies
- Advancements in Genome Editing
- The Medical Chemistry in the Era of Machines and Automation
- The Evolving Role of Machine Learning and AI in Computational Chemistry
- Computer Aided Drug Design Approaches against SARS-CoV-2
- Deep Generative Models for Target-Specific & Selective Drug Design